TABLE 2.
Number of participants suffering exacerbation events (prescriptions for antibiotics or corticosteroids or both in the community or admissions to hospital) grouped by the number of events recorded during the 6-week reference period in each year
| 2019 | 2020 | |
| Participants | 160 | 160 |
| Community and hospital managed AECOPD events n | ||
| 0 | 106 (66) | 105 (66) |
| 1 | 14 (9) | 10 (6) |
| 2 | 35 (22) | 21 (13) |
| 3 | 5 (3) | 22 (14) |
| 4 | 0 (0) | 2 (1) |
| Community managed AECOPD events n | ||
| 0 | 112 (70) | 107 (67) |
| 1 | 9 (6) | 9 (6) |
| 2 | 38 (24) | 21 (13) |
| 3 | 1 (1) | 22 (14) |
| 4 | 0 (0) | 1 (1) |
| Hospital managed AECOPD events n | ||
| 0 | 150 (94) | 155 (97) |
| 1 | 9 (6) | 5 (3) |
| 2 | 1 (1) | 0 (0) |
Data are presented as n or n (%). AECOPD: acute exacerbations of chronic obstructive pulmonary disease. Behaviour pre-lockdown and lockdown compared with baseline.